Eloxx Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020GlobeNewsWire • 07/21/20
Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Pharmacology and Experimental TherapeuticsGlobeNewsWire • 07/15/20
Enrollment in Phase 2 Clinical Trial in Cystic Fibrosis Has Been Resumed in Israel and Europe After Being Paused Temporarily in Response to the COVID-19 PandemicGlobeNewsWire • 06/17/20
Eloxx Pharmaceuticals, Inc. (ELOX) CEO Greg Williams on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/11/20
Eloxx Pharmaceuticals Provides Update on the Impact of Novel Coronavirus (COVID-19) on Phase 2 Clinical Trials in Cystic FibrosisGlobeNewsWire • 03/25/20
Eloxx Pharmaceuticals, Inc. (ELOX) CEO Greg Williams on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/06/20
Eloxx Strengthens its Commitment to Cystic Fibrosis Through Reallocating ResourcesGlobeNewsWire • 02/26/20
Eloxx Pharmaceuticals Provides Update on Progress of Its Phase 2 Clinical Programs for ELX-02 and ERSG Pipeline at Biotech Showcase™GlobeNewsWire • 01/14/20
Eloxx Pharmaceuticals, Inc. (ELOX) Shares March Higher, Can It Continue?Zacks Investment Research • 12/06/19
Eloxx Pharmaceuticals, Inc. (ELOX) CEO Robert Ward on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/10/19
Eloxx Pharmaceuticals Presents New Positive Data for ELX-02 at the American Society of Nephrology (ASN) Kidney Week 2019GlobeNewsWire • 11/07/19
Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide Funding and Support for ELX-02 U.S. Phase 2 Clinical TrialGlobeNewsWire • 09/23/19
Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on October 3rd, 2019GlobeNewsWire • 09/16/19
Eloxx Pharmaceuticals to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases on September 24, 2019GlobeNewsWire • 09/10/19
Eloxx Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 5th, 2019GlobeNewsWire • 08/26/19
Eloxx Pharmaceuticals, Inc. (ELOX) CEO Robert Ward on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/09/19
Eloxx Pharmaceuticals' (ELOX) CEO Robert Ward on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/10/19